Category: Business

The lawn-and-garden giant’s CEO says its cannabis unit could be “more valuable” as a stand-alone business.
The post Scotts Miracle-Gro aims to break up with Hawthorne as growth prospects dim appeared first on Green Market Report.

The measure would make sweeping changes, such as gutting social equity provisions and restricting the number of licenses.
The post Ohio Republicans poised to tighten cannabis industry rules, raise taxes appeared first on Green Market Report.

Stagnate same-store sales and an non-cash impairment dragged down the Canadian company’s results.
The post High Tide posts C$3.8 million loss for fiscal year 2024 appeared first on Green Market Report.

Share-based compensation expenses weighed on the company’s bottom line.
The post Nextleaf loss widens despite 66% revenue growth in 2024 appeared first on Green Market Report.

The cannabis banking firm tapped an industry turnaround expert as new chief executive as Seefried plans retirement.
The post Safe Harbor Financial CEO to step down, successor named appeared first on Green Market Report.

The Canadian drug maker reported its largest MDMA capsule production run to date following more expansion overseas.
The post Optimi Health beefs psychedelic footprint, nabs new funding appeared first on Green Market Report.

Despite Hawthorne’s improved performance, Scotts expects the division’s sales to decline by mid-single digits this fiscal year.
The post Scotts’ Hawthorne unit posts profit despite sharp sales drop appeared first on Green Market Report.

Unfortunately, the Farm Bill is not seen as an urgent item for politicians to address.
The post Safe, Safer, Safest? Cannabis banking bill isn’t dead appeared first on Green Market Report.

The campaign, which was funded with cannabis tax dollars, used racist imagery and debunked myths about the drug.
The post New Colorado anti-cannabis campaign highlights need for political vigilance appeared first on Green Market Report.

The move expands access to the novel mental health treatment, which has shown rapid symptom improvement for the past few years now.
The post FDA approves J&J’s esketamine as stand-alone depression treatment appeared first on Green Market Report.